Ambagon Therapeutics
VerifiedBiotechnology company that is developing cancer molecule therapeutics.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$340—510m (Dealroom.co estimates Jan 2022.)
California United States (HQ), Eindhoven Noord-Brabant (founding location)
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor investor investor | $0.0 | round |
investor | $0.0 | round | |
* | $85.0m | Series A | |
Total Funding | 000k |